ReleaseWire Connect

Proton therapy is an advanced form of radiation therapy especially for cancer patients with significant advantages over conventional radiation therapy in terms of efficacy and unwanted side effects. In proton therapy a beam of protons is irradiated to diseased tissue with the help of a particle accelerator. These protons cause damage to targeted cells by interfering with their genetic functions. Protons, due to their large mass do not scatter side and are more precisely localized to targeted tissue allowing significantly less damage to adjacent cells. According to The National Association for Proton Therapy, there are 10 to 12 centers providing proton therapy treatment across United States including UC Davis Crocker Lab, Indiana University Health Proton Therapy Center and M. D. Anderson Cancer Center and 8 new centers are in development. Proton Treatment Center at Loma Linda University Medical Center was the first facility to treat its patient with proton therapy in 1990. Since then the world has witnessed a massive growth taking place in the development of other centers across the globe. Today, other centers are operating in countries such as Sweden, Japan, Canada, China, Germany and France. In coming years few more centers are about to be established in countries such as Poland, Austria, Hungary, Russia and Australia.

According to a new market report published by Transparency Market Research "Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the pharmacy automation systems market was valued at USD 4.7 billion in 2011 globally and is expected to grow to USD 7.8 billion by 2018, at a CAGR of 7.3% from 2012 to 2018.

Transparency Market Research has announced the addition of a new market intelligence report titled, “Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," to its offering. The report articulates that the global Peptide therapeutics market, which was worth approximately 14.1 billion in 2011, is estimated to grow at an average CAGR of 8.7% and reach an approximate value of USD 25.4 billion at the end of the forecast period that ranges from 2012 to 2018.

Proteins are essential for good health; people affected by genetic disorders cannot produce these proteins. Examples of such proteins include insulin, various blood clotting factors, growth hormones and others. Protein therapy ensures efficient administration of these proteins to patients suffering from deficiency, resulting in effective therapeutic benefits. It is a type of medical treatment that possesses therapeutic effects in many diseases such as diabetes, brain diseases and cancer.

The pharmaceutical industry is witnessing a shift in focus from molecular drugs to protein based drugs due to its high specificity, enhanced efficacy, affinity, solubility, and low incidences of toxicity. The market for protein drugs is segmented into antibody drugs, peptide hormones, blood products and enzymes market. The antibody segment is one of the fastest growing areas in this market. Some of the commercially available antibody drugs are Adcetris (brentuximab vedotin) marketed by Seattle Genetics and Millennium/Takeda and Kadcyla (trastuzumab emtansine) marketed by Genentech and Roche. Insulin was the first peptide isolated and used as a therapeutic agent. Today there is a long list of peptides used therapeutically such as octreotide used in cancer treatment, amylin, pramlintide and glucagon-like peptide-1 (GLP-1). Rituxan (rituximab), Erbitux (cetuximab) are leading brand names in the monoclonal antibodies segment.

Tissue engineering and organ regeneration market encompasses those products used in medicine. The application of these new age biomaterials include burn treatment or wound care, orthopaedics, urological products, and neurology products. Engineered cell growth has been present over the past many years with little or no applications in medicine. Recent developments and progress in the field of stem cell technology, cell culture technology and immunopassivation and immunomodulation has provided incredible opportunities to market players. Several cardiovascular applications such as heart valve and myocardial tissue regeneration is also expected to provide excellent sustainability for the growth of the market. Rising cost of organ transplantation, long waiting lines and rising medical applications of 3D printing in tissue and organ regeneration will be the major growth drivers for this market in the near future.

Organ transplant immunosuppressants are a class of drugs administered to lower the chances of organ rejection after a transplant and are also called as anti-rejection drugs. When a person gets an organ transplant such as kidney, liver or heart, the body identifies transplant as a foreign tissue and attacks it causing severe rejection. These immunosuppressant drugs weaken the immune system thereby decreasing the body’s reaction to transplant. Almost every person undergoing a solid organ transplant requires to take immunosuppressant drugs. Therefore the global market for these drugs is sharply rising with increase in the number of organ transplants across the globe.

The global caprolactam market is growing at a significant rate in the current economy. This growth is primarily driven by increasing demand for engineering and electronics applications of caprolactam. Caprolactam is manufactured by synthesis of phenol or cyclohexane. This artificial chemical can be synthesized in a manner befitting a spectrum of applications. The commercial versions of caprolactam are known as nylon 6 resin and nylon 6 fiber. Depending on the chemical and physical attributes, caprolactam is utilized in many different applications such as nets, fishing lines, industrial yarns, carpets, and textiles.

The global pesticides market has been growing significantly in the recent years. The growth has been especially a noticeable one in the India, China, and Japan pesticide market. The main reason for augmenting pesticides market in these regions is a huge agriculture-based economy. As pesticides help in destroying, attacking, and mitigating the loss caused by pests to the crops they are extensively used in farming. Pesticides are substances that are made up some a combination of chemicals that eliminate and help in arresting the growth of harmful insects, fungi, herbs, pests, and other such organisms that negatively impact the crop cultivation.

The leading market for propionic acid belongs to Europe, which has recorded a CAGR of 2.1% from 2013 to 2019. The Asia-Pacific region’s propionic acid market shows the fastest growth with a CAGR of 2.9% and stands in the third position. North America holds the second position in market size with 29.8% of the global propionic acid consumed in 2012.